seca Launches First Body Composition Scan for Primary Care

What You Should Know:

–  seca, the global leader in medical measuring and weighing, today announced the latest addition to its line of advanced body composition analyzers, mBCA Alpha (Alpha), a compact, portable scanner specifically designed for use in a primary care setting.

–   This new product further enhances seca’s transformation from a measuring and weighing company to a modern technology-first solutions partner, making body composition screenings more accessible to all providers–not just specialists.

seca Launches Alpha: Revolutionizing Body Composition Assessment in Primary Care

seca, a global leader in precision medical measurement, has unveiled Alpha, a breakthrough body composition analyzer designed to advance obesity and metabolic care in primary care settings. Backed by over 185 years of German engineering excellence, seca continues to set the global standard for innovation, accuracy, and clinical integration in medical body composition analysis.

Redefining Clinical Assessment Beyond BMI
Historically, primary care teams relied on weight and body mass index (BMI) to evaluate risks associated with chronic conditions like obesity, diabetes, and cardiovascular disease. However, BMI has increasingly been criticized as outdated, oversimplified, and potentially biased. Alpha transforms this approach by providing rapid, comprehensive insight into:

• Fat mass
• Muscle mass
• Visceral fat
• Hydration status
• Medication impact (e.g., GLP-1s)
• Early signs of sarcopenia and excess adiposity

Powered by seca’s proprietary Analytics 125 platform, Alpha delivers full-body composition results in just 24 seconds using validated bioelectrical impedance analysis (BIA). The system supports longitudinal care through seamless access to:

• Cloud-based reporting
• seca’s Treatment Tracker platform
• A patient-facing app enabling real-time data sharing and monitoring

Clinically Validated for Superior Accuracy
seca’s bioimpedance solutions, including Alpha, demonstrate exceptional clinical reliability—achieving:

• 97% correlation with whole-body MRI
• 98% agreement with the 4-compartment gold standard model for fat mass

By prioritizing scientific rigor, seca ensures that care teams base treatment decisions on the highest quality of data available.

Driving a New Standard in Longitudinal Obesity Care
Alpha’s integration into primary care workflows empowers providers to deliver more personalized, data-driven diagnoses and treatment plans. This aligns with the broader healthcare shift toward precision, prevention, and continuity of care.

Nina Crowley, PhD, RD, Director of Clinical Education and Partnerships at seca, emphasized:

“We are witnessing a clinical transformation as clinicians and patients realize that BMI is no longer enough. Alpha was built to reflect how today’s clinicians work—quickly, accurately, and intuitively.”

Expanding the Ecosystem: Treatment Tracker
The Alpha launch follows the introduction of Treatment Tracker, seca’s industry-first solution that merges treatment plans with body composition results. This integrated platform allows providers to monitor interventions, visualize progress, and adjust care in real time.